The UK's High Court revoked Human Genome Sciences' patent on neutrokine-alpha, a protein involved in a number of inflammatory diseases, such as arthritis, asthma and chronic pulmonary disease, says the Financial Times.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.